Epigenetics discovery aids prostate cancer diagnosis

A lot of attention has been placed on the genetics of cancer, including looking at the mutations that occur that enable a small cohort of cells to maintain runaway growth. But cancer also sees changes occur at the epigenetic level, switching key genes on and off to enable it to grow and spread.

Now researchers at Sydney’s Garvan Institute have revealed the role of one non-coding microRNA (miRNA) which appears to play a significant role in prostate cancer and is closely linked to the prognosis of cancer patients. The discovery opens up the possibility of developing a new diagnostic tool as well as yielding an insight into how prostate cancer proliferates, and how it might potentially be stopped.

View the original article here: Epigenetics discovery aids prostate cancer diagnosis – Australian Life Scientist

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
seralinistud

Gilles-Éric Séralini: Activist professor and face of anti-GMO industry

The French biologist and his research team--funded by the Rodale ...
vandana shiva

Vandana Shiva: ‘Rock Star’ of GMO protest movement has anti-science history

In a 2012 interview, Bill Moyers referred to Vandana Shiva as ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend